Clovis Oncology

About:

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments.

Website: http://clovisoncology.com/

Top Investors: New Enterprise Associates, Versant Ventures, Frazier Healthcare Partners, Abingworth, Domain Associates

Description:

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.

Total Funding Amount:

$145M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2009-01-01

Founders:

Gillian C. Ivers-Read, Patrick Mahaffy

Number of Employees:

251-500

Last Funding Date:

2011-06-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai